Molecular Phenotype of the Developing Heart with a Congenital Anomaly

  • Theodorus H. F. Peters
  • Lennart Klompe
  • J. J. C. Bogers
  • Hari S. Sharma
Part of the Progress in Experimental Cardiology book series (PREC, volume 4)


A high prevalence of congenital heart malformations accounts for defects in the outflow tract accompanied with right ventricular hypertrophy (KVH), such as in case of tetralogy of Fallot (ToF) and in pulmonary atresia (PA) with a ventricular septal defect (VSD). The etiology and contributing molecular events in cardiovascular malformations are poorly understood. These patients require primary corrective surgical repair at young age, which is now a treatment of choice where closing of the VSD and removing the right ventricular outflow tract obstruction are performed. In the past years, we have been investigating the myocardial molecular phenotype at various stages of KVH in ToF and PA/VSD. In the study, summarised in this chapter, we assessed the surface area of cells in right ventricular biopsies and examined the myocardial fibrosis by measuring total collagen and fibronectin expression both at mRNA and protein level. Assessment of myocardial cell hypertrophy revealed significantly enlarged (p < 0.01) cells in adult (>25yr.) patients with ToF as compared to age matched controls. Immunohistochemical staining of biopsies for collagen followed by video image analysis showed significantly enhanced interstitial collagen levels in adult ToF as compared to young (<2yr.) controls (p < 0.05) and young ToF patients (p < 0.01). In PA/VSD patients however, interstitial collagen levels did not change as compared to respective age matched controls. Interestingly, peri-vascular collagen deposition increased in young ToF patients as compared to young and adult controls. In contrast, the staining levels of both collagens and fibronectin were lower in the PA/VSD patients as compared to respective controls. Interstitial expression of fibronectin in ToF patents remained unchanged. RT-PCR analysis for collagen la, collagen III and fibronectin expression levels in PA/VSD patients showed only higher collagen III mRNA expression in PA/VSD patients as compared to respective age matched controls. We conclude that the enhanced myocyte size and increased extracellular matrix deposition and disarray of collagen and fibronectin are signs of fibrosis during RVH that contribute to diminished right ventricular function in patients with ToF and PA/VSD.

Key words

tetralogy of Fallot right ventricle hypertrophy pulmonary atresia and fibrosis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bogers AJ, van der Laarse A, Vliegen HW, Quaegebeur JM, Hollaar L, Egas JM, Cornelisse CJ, Rohmer J, Huysmans HA. 1988. Assessment of hypertrophy in myocardial biopsies taken during correction of congenital heart disease. Thorac Cardiovasc Surgeon 36:137–140.CrossRefGoogle Scholar
  2. 2.
    Pozzi M, Trivedi DB, Kitchiner D, Arnold RA. 2000. Tetralogy of Fallot: what operation, at which age. Eur J Cardiothorac Surg 17:631–636.PubMedCrossRefGoogle Scholar
  3. 3.
    Starnes VA, Luciani GB, Latter DA, Griffin ML. 1994. Current surgical management of tetralogy of Fallot. Ann Thorac Surg 58:211–215.PubMedCrossRefGoogle Scholar
  4. 4.
    Warner KG, Anderson JE, Fulton DR, Payne DD, Geggel RL, Marx GR. 1993. Restoration of the pulmonary valve reduces right ventricular volume overload after previous repair of tetralogy of Fallot. Circulation 88:11189–197.Google Scholar
  5. 5.
    Murphy JG, Gersh BJ, Mair DD, Fuster V, McGoon MD, Ilstrup DM, McGoon DC, Kirklin JW, Danielson GK. 1993. Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med 329:593–599.PubMedCrossRefGoogle Scholar
  6. 6.
    Schwartz SM, Gordon D, Mosca RS, Bove EL, Heidelberger KP, Kulik TJ. 1996. Collagen content in normal, pressure, and pressure-volume overloaded developing human hearts. Am J Cardiol 77:734–738.PubMedCrossRefGoogle Scholar
  7. 7.
    Arai M, Matsui H, Periasamy M. 1994. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res 74:555–564.PubMedCrossRefGoogle Scholar
  8. 8.
    Mitsuno M, Nakano S, Shimazaki Y, Taniguchi K, Kawamoto T, Kobayashi J, Matsuda H, Kawashima Y. 1993. Fate of right ventricular hypertrophy in tetralogy of Fallot after corrective surgery. Am J Cardiol 72:694–698.PubMedCrossRefGoogle Scholar
  9. 9.
    Seliem MA, Wu YT, Glenwright K. 1995. Relation between age at surgery and regression of right ventricular hypertrophy in tetralogy of Fallot. Pediatr Cardiol 16:53–55.PubMedCrossRefGoogle Scholar
  10. 10.
    Bishop SP. 1984. Structural alterations in the hypertrophied and failing myocardium. In: Functional aspects of the normal hypertrophied and failing heart. Eds. FL Abel and WH Hewman, 278–300. The Hague: Martinus Nijhoff Publishing.CrossRefGoogle Scholar
  11. 11.
    Boheler KR, Dillmann WH. 1988. Cardiac response to pressure overload in the rat: the selective alteration of in vitro directed RJSTA translation products. Circulation Res 63:448–456.PubMedCrossRefGoogle Scholar
  12. 12.
    Brand T, Sharma HS, Schaper W 1993. Expression of nuclear proto-oncogenes in isoproterenolinduced cardiac hypertrophy. J Mol Cell Cardiol 25:1325–1337.PubMedCrossRefGoogle Scholar
  13. 13.
    Tomanek RJ, Torry RJ. 1994. Growth of the coronary vasculature in hypertrophy: mechanisms and model dependence. Cell Mol Biol Res 40:129–136.PubMedGoogle Scholar
  14. 14.
    Vikstrom KL, Bohlmeyer T, Factor SM, Leinwand LA. 1998. Hypertrophy, pathology, and molecular markers of cardiac pathogenesis. Circ Res 82:773–778.PubMedCrossRefGoogle Scholar
  15. 15.
    Brilla CG, Janicki JS, Weber KT. 1991. Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res 69:107–115.PubMedCrossRefGoogle Scholar
  16. 16.
    Brilla CG, Janicki JS, Weber KT. 1991. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 83(5):1771–1779.PubMedCrossRefGoogle Scholar
  17. 17.
    Weber KT, Brilla CG. 1991. Pathological hypertrophy and cardiac interstitium. Fibrosis and reninangiotensin-aldosterone system. Circulation 83 (6): 1849–1865.PubMedCrossRefGoogle Scholar
  18. Schwartz K, Carrier L, Mercadier JJ, Lompre AM. 1993. Molecular phenotype of the hypertrofied and failing myocardium. Circulation 87:VII5–10.Google Scholar
  19. 19.
    Pelouch V, Dixon IM, Golfman L, Beamish RE, Dhalla NS. 1994. Role of extracellular matrix proteins in heart function. Mol Cell Biochem 129:101–120.CrossRefGoogle Scholar
  20. 20.
    Ignotz RA, Massague J. 1986. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261(9):4337–4345.PubMedGoogle Scholar
  21. 21.
    Chapman D, Weber KT, Eghbali M. 1990. Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in pressure overloaded rat myocardium. Circ Res 67:787–794.PubMedCrossRefGoogle Scholar
  22. 22.
    Volders PG, Willems IE, Cleutjens JP, Arends JW, Havenith MG, Daemen MJ. 1993. Interstitial collagen is increased in the non-infarcted human myocardium after myocardial infarction. J Mol Cell Cardiol 25:1317–1323.PubMedCrossRefGoogle Scholar
  23. 23.
    Bishop JE, Rhodes S, Laurent GJ, Low RB, Stirewalt WS. 1994. Increased collagen synthesis and decreased collagen degradation in right ventricular hypertrophy induced by pressure overload. Cardiovasc Res 28:1581–1585.PubMedCrossRefGoogle Scholar
  24. 24.
    Weber KT, Sun Y, Tyagi SC, Cleutjens JP. 1994. Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol 26:279–292.PubMedCrossRefGoogle Scholar
  25. 25.
    Caspari PG, Gibson K, Harris P. 1976. Changes in myocardial collagen in normal development and after β-blockade. Rec Adv Card Struct Metab 7:99–104.Google Scholar
  26. 26.
    van Bilsen M, Chien KR. 1993. Growth and hypertrophy of the heart: towards an understanding of cardiac specific and inducable gene expression. Cardiovasc Res 27:1140–1149.PubMedCrossRefGoogle Scholar
  27. 27.
    Zak R. 1973. Cell proliferation during cardiac growth. Am J Cardiol 31:211–219.PubMedCrossRefGoogle Scholar
  28. 28.
    Farhadian F, Contard F, Corbier A, Barrieux A, Rappaport L, Samuel JL. 1995. Fibronectin expression during physiological and pathological cardiac growth. J Mol Cell Cardiol 27:981–990.PubMedCrossRefGoogle Scholar
  29. 29.
    Borg TK, Caulfield JB. 1981. The collagen matrix of the heart. Fed Proc 20:2037–2041.Google Scholar
  30. 30.
    Factor SM, Robinson TF, Dominitz R, Cho S. 1986. Alterations of the myocardial skeletal framework in acute myocardial infarction with and without ventricular rupture. Am J Cardiovasc Pathol 1:91–97.Google Scholar
  31. 31.
    Whittaker P. 1997. Collagen and ventricular remodeling after acute myocardial infarction: concepts and hypotheses. Basic Res Cardiol 92:79–81.PubMedGoogle Scholar
  32. 32.
    Samuel JL, Barrieux A, Dufour S, Dubus I, Contard F, Koteliansky V, Farhadian F, Marotte F, Thiery JP, Rappaport L. 1991. Accumulation of fetal fibronectin mRNAs during the development of rat cardiac hypertrophy induced by pressure overload. J Clin Invest 88:1737–1746.PubMedCrossRefGoogle Scholar
  33. 33.
    McLenachan JM, Dargie HJ. 1990. Ventricular airhythmias in hypertensive left ventricular hypertrophy. Relationship to coronary artery disease, left ventricular dysfunction, and myocardial fibrosis. Am J Hypertens 3:735–740.PubMedGoogle Scholar
  34. 34.
    Speranza ML, Valentini G, Calligaro A. 1987. Influence of fibronectin on the fibrillogenesis of type I and type III collagen. Coll Relat Res 7:115–123.PubMedCrossRefGoogle Scholar
  35. 35.
    Bogers AJJC, Roofthooft M, Pisters H, Spitaels SEC, Bos E. 1994. Longterm follow-up of gamma irradiated transannular homograft patch in surgical treatment of tetralogy of Fallot. Thorac Cardiovasc Surgeon 42:337–339.CrossRefGoogle Scholar
  36. 36.
    Hokken RB, Bogers AJJC, Spitaels SEC, Hess J, Bos E. 1995. Pulmonary homograft insertion after repair of pulmonary stenosis. J Heart Valve Dis 4:182–186.PubMedGoogle Scholar
  37. 37.
    Bancroff JD, Cook HC. 1994. Manual of Histological Techniques and Their Diagnostic Aplication, Eds. JD Bancroff and HC Cook, 53. London: Churchil livingstone.Google Scholar
  38. 38.
    Sharma HS, van Heugten HA, Goedbloed MA, Verdouw PD, Lamers JM. 1994. Angiotensin II induced expression of transcription factors precedes increase in Transforming Growth Factor-β mRNA in neonatal cardiac fibroblasts. Biochem Biophys Res Comm 205:105–112.PubMedCrossRefGoogle Scholar
  39. 39.
    Bernard MP, Chu ML, Myers JC, Ramirez F, Eikenberry EF, Prockop DJ. 1983. Nucleotide sequence of complementary deoxyribonucleic acids for the pro alpha 1 chain of human type 1 procollagen. Statistical evaluation of structures that are conserved during evolution. Biochem 22:5213–5223.CrossRefGoogle Scholar
  40. 40.
    Ala-Kokko L, Kontusaari S, Baldwin CT, Kuivaniemi H, Prockop DJ. 1989. Structure of cDNA clones coding for the entire prepro alpha 1 chain of human type III procollagen. Differences in protein structure from type I procollagen and conservation of codon preferences. Biochem J 260: 509–516.PubMedGoogle Scholar
  41. 41.
    Kornblihtt AR, Vibe-Petersen K, Baralle FE. 1983. Isolation and characterization of cDNA clones for human and bovine fibronectins. Proc Nad Acad Sci USA 80(11):3218–3222.CrossRefGoogle Scholar
  42. 42.
    Yamaguchi T, Iwano M, Kubo A, Hirayama T, Akai Y, Horii Y, Fujimoto T, Hamaguchi T, Kurumatani N, Motomiya Y, Dohi K. 1996. IL-6 mRNA synthesis by peripheral blood mononuclear cells (PBMC) in patients with chronic renal failure. Clin Exp Immunol 103:279–328.PubMedCrossRefGoogle Scholar
  43. 43.
    Peters TH, Sharma HS, Yilmaz E, Bogers AJ. 1999. Quantitative analysis of collagens and fibronectin expression in human right ventricular hypertrophy. Ann NY Acad Sci 874:278–285.PubMedCrossRefGoogle Scholar
  44. 44.
    Sharma HS, Peters THF, Bogers AJJC. 2000. Angiogenesis and fibrosis during right ventricular hypertrophy in human tetralogy of Fallot. In: The hypertrophied heart, Eds. N Takeda, M Nagano and NS Dhalla, 227–241. Boston, USA: Kluwer Academic Publishers.CrossRefGoogle Scholar
  45. 45.
    Kawai S, Okada R, Kitamura K, Suzuki A, Saito S. 1984. A morphometrical study of myocardial disarray associated with right ventricular outflow tract obstruction. Jpn Circ J 48:445–456.PubMedCrossRefGoogle Scholar
  46. 46.
    Limoto DS, Covell JW, Harper E. 1988. Increase in crosslinking of type I and type III collagens associated with volume-overloaded hypertrophy. Circ Res 63:399–408.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Theodorus H. F. Peters
    • 1
    • 2
  • Lennart Klompe
    • 1
    • 2
  • J. J. C. Bogers
    • 2
  • Hari S. Sharma
    • 1
  1. 1.Departments of PharmacologyErasmus University Medical Center RotterdamRotterdamThe Netherlands
  2. 2.Cardio-thoracic SurgeryErasmus University Medical Center RotterdamRotterdamThe Netherlands

Personalised recommendations